Published in N Engl J Med on July 24, 2008
TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial. Trials (2015) 1.41
Telmisartan in the diabetic murine model of acute myocardial infarction: dual contrast manganese-enhanced and delayed enhancement MRI evaluation of the peri-infarct region. Cardiovasc Diabetol (2016) 0.75
Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med (2010) 5.50
Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA (2009) 3.83
CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70
TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol (2008) 2.23
Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol (2004) 2.18
Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A (2009) 1.95
The mesangial cell revisited: no cell is an island. J Am Soc Nephrol (2009) 1.87
Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet (2012) 1.68
Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD. PLoS Genet (2011) 1.68
Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney Int (2011) 1.64
Effects of donor pre-treatment with dopamine on survival after heart transplantation: a cohort study of heart transplant recipients nested in a randomized controlled multicenter trial. J Am Coll Cardiol (2011) 1.63
The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol (2004) 1.54
Modifying effects of the R389G beta1-adrenoceptor polymorphism on resting heart rate and blood pressure in patients with obstructive sleep apnoea. Clin Sci (Lond) (2006) 1.44
Long-term results of pancreas transplantation in patients older than 50 years. Transpl Int (2010) 1.44
Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol (2006) 1.28
Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors. J Am Soc Nephrol (2003) 1.25
TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells. Cytokine (2009) 1.20
Identification of novel beta1 integrin binding sites in the type 1 and type 2 repeats of thrombospondin-1. J Biol Chem (2004) 1.19
Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study. Transplantation (2005) 1.17
Gene expression of adenosine receptors along the nephron. Kidney Int (2004) 1.14
OSAKA trial: a randomized, controlled trial comparing tacrolimus QD and BD in kidney transplantation. Transplantation (2013) 1.14
Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. Hum Mol Genet (2012) 1.14
Effect of chronic kidney disease and comorbid conditions on health care costs: A 10-year observational study in a general population. Am J Nephrol (2009) 1.13
Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease. Kidney Int (2004) 1.13
Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome. Eur J Heart Fail (2011) 1.13
The chemokine receptor 5 Delta32 mutation is associated with increased renal survival in patients with IgA nephropathy. Kidney Int (2005) 1.07
Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation. Intensive Care Med (2009) 1.07
Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease. Clin J Am Soc Nephrol (2008) 1.05
Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. J Am Soc Nephrol (2005) 1.03
Carnosine prevents apoptosis of glomerular cells and podocyte loss in STZ diabetic rats. Cell Physiol Biochem (2011) 1.03
Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases. Am J Kidney Dis (2004) 1.02
RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients. Atherosclerosis (2005) 1.02
Preserved macula densa-dependent renin secretion in A1 adenosine receptor knockout mice. Am J Physiol Renal Physiol (2002) 1.00
Localization of TGF-beta signaling intermediates Smad2, 3, 4, and 7 in developing and mature human and mouse kidney. J Histochem Cytochem (2006) 0.99
Calcineurin inhibitor minimization protocols in liver transplantation. Transpl Int (2009) 0.97
Angiotensin inhibition reduces glomerular damage and renal chemokine expression in MRL/lpr mice. J Pharmacol Exp Ther (2003) 0.97
CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol (2004) 0.97
Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial. Transplantation (2010) 0.96
[A 93-year-old patient with hypertensive crises and renal failure due to bilateral renal artery stenosis]. MMW Fortschr Med (2015) 0.96
A Monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation. J Am Soc Nephrol (2002) 0.95
Current concepts and perspectives of immunosuppression in organ transplantation. Langenbecks Arch Surg (2007) 0.94
Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodies. J Am Soc Nephrol (2005) 0.92
Effects of chemokines on proliferation and apoptosis of human mesangial cells. BMC Nephrol (2004) 0.91
Angiotensin II inhibits renin gene transcription via the protein kinase C pathway. Pflugers Arch (2002) 0.91
Risk factors and myocardial infarction in patients with obstructive sleep apnea: impact of beta2-adrenergic receptor polymorphisms. BMC Med (2007) 0.91
Calcium inhibits renin gene expression by transcriptional and posttranscriptional mechanisms. Hypertension (2005) 0.90
Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. Am J Kidney Dis (2004) 0.90
High-level connexin expression in the human juxtaglomerular apparatus. Nephron Physiol (2010) 0.90
Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes. Transplantation (2007) 0.90
Clinical management of large adrenal cystic lesions. Int Urol Nephrol (2005) 0.89
Obstructive sleep apnea and blood pressure. Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs. Am J Hypertens (2004) 0.89
Alkylphosphocholines inhibit proliferation of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2003) 0.87
Ultrafiltration in heart failure with cardiorenal syndrome. N Engl J Med (2013) 0.87
Quantitative renal perfusion measurements in a rat model of acute kidney injury at 3T: testing inter- and intramethodical significance of ASL and DCE-MRI. PLoS One (2013) 0.87
Angiotensin II feedback is a regulator of renocortical renin, COX-2, and nNOS expression. Am J Physiol Regul Integr Comp Physiol (2002) 0.87
Nephron specific regulation of chloride channel CLC-K2 mRNA in the rat. Kidney Int (2002) 0.86
Impact of chemokine receptor CX3CR1 in human renal allograft rejection. Transpl Immunol (2010) 0.86
Experimental diabetes and left ventricular hypertrophy: effects of beta-receptor blockade. Cardiovasc Pathol (2002) 0.85
Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantation. Transpl Int (2012) 0.85
Donor desmopressin is associated with superior graft survival after kidney transplantation. Transplantation (2011) 0.85
Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results. Nephrol Dial Transplant (2008) 0.85
Different conformational forms of serum carnosinase detected by a newly developed sandwich ELISA for the measurements of carnosinase concentrations. Amino Acids (2012) 0.85
Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation. Clin Transplant (2005) 0.85
BK virus associated nephropathy in native kidneys of a heart allograft recipient. Am J Transplant (2005) 0.84
N-octanoyl-dopamine is an agonist at the capsaicin receptor TRPV1 and mitigates ischemia-induced [corrected] acute kidney injury in rat. PLoS One (2012) 0.84
Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis. Am J Kidney Dis (2002) 0.84
Nephron-specific expression of components of the renin-angiotensin-aldosterone system in the mouse kidney. J Renin Angiotensin Aldosterone Syst (2012) 0.84
Impact of iso- and low-osmolar iodinated contrast agents on BOLD and diffusion MRI in swine kidneys. Invest Radiol (2012) 0.84
Association of chronic kidney disease with adverse outcomes. Lancet (2013) 0.84
The impact of polymorphisms in chemokine and chemokine receptors on outcomes in liver transplantation. Am J Transplant (2002) 0.84
A comprehensive genotype-phenotype interaction of different Toll-like receptor variations in a renal transplant cohort. Clin Sci (Lond) (2010) 0.84
Dopamine and lipophilic derivates protect cardiomyocytes against cold preservation injury. J Pharmacol Exp Ther (2013) 0.83
Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial. Transplantation (2012) 0.82
Effect of membrane flux and dialyzer biocompatibility on survival in end-stage diabetic nephropathy. Nephron Clin Pract (2008) 0.82
Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study. Nephrol Dial Transplant (2006) 0.82
Upregulation of macula densa cyclooxygenase-2 expression is not dependent on glomerular filtration. Am J Physiol Renal Physiol (2004) 0.82
Common variants in Mendelian kidney disease genes and their association with renal function. J Am Soc Nephrol (2013) 0.82
C-reactive protein as predictor of death in end-stage diabetic nephropathy: role of peripheral arterial disease. Kidney Int (2005) 0.82
Quantification and excretion kinetics of a magnetic resonance imaging contrast agent by capillary electrophoresis-mass spectrometry. Electrophoresis (2009) 0.81
UW is superior compared with HTK after prolonged preservation of renal grafts. J Surg Res (2011) 0.81
Elevated urinary sVCAM-1, IL6, sIL6R and TNFR1 concentrations indicate acute kidney transplant rejection in the first 2 weeks after transplantation. Cytokine (2011) 0.81
Central vein stenosis in a dialysis patient: a case report. J Med Case Rep (2012) 0.81
Alkylphosphocholines: a new therapeutic option in glaucoma filtration surgery. Invest Ophthalmol Vis Sci (2004) 0.80
Smoking behaviour of patients before and after renal transplantation. Nephrol Dial Transplant (2007) 0.80
Impact of Toll-like receptor 2 expression in renal allograft rejection. Nephrol Dial Transplant (2010) 0.80
Hypertonic stress promotes the upregulation and phosphorylation of zonula occludens 1. Nephron Physiol (2011) 0.80